MANF could be to AMBS to what Eylea is to Reg
Post# of 30028
Posted On: 01/20/2015 11:49:33 PM
MANF could be to AMBS to what
Eylea is to Regeneron - per GC
Since 2011, Eylea net U.S. sales have skyrocketed and illustrated how a blockbuster drug transforms a company. Those annual sales started at $25 million in 2011, before spiking to $838 million in 2012, the filing shows. The net U.S. sales nearly doubled again in 2013, when they totaled $1.41 billion.
http://www.bizjournals.com/albany/blog/health...-1-74.html
Eylea is to Regeneron - per GC
Since 2011, Eylea net U.S. sales have skyrocketed and illustrated how a blockbuster drug transforms a company. Those annual sales started at $25 million in 2011, before spiking to $838 million in 2012, the filing shows. The net U.S. sales nearly doubled again in 2013, when they totaled $1.41 billion.
http://www.bizjournals.com/albany/blog/health...-1-74.html
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼